Prospects for the use of antagonists to the platelet glycoprotein IIb/ IIIa receptor to prevent postangioplasty restenosis and thrombosis

This publication has 51 references indexed in Scilit:

• Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
  Journal of the American College of Cardiology, 1988
• Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids
  New England Journal of Medicine, 1988
• Guidelines for percutaneous transluminal coronary angioplasty
  Journal of the American College of Cardiology, 1988
• Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
  New England Journal of Medicine, 1988
• Results of percutaneous transluminal coronary angioplasty by multiple, relatively low frequency operators: 1986–1987 experience
  The American Journal of Cardiology, 1988
• Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
  Journal of Clinical Investigation, 1988
• Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.
  Journal of Clinical Investigation, 1988
• Platelet/Vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: Preventive strategies
  The American Journal of Cardiology, 1987
• Molecular Defects in Interactions of Platelets with the Vessel Wall
  New England Journal of Medicine, 1984
• Exposure of platelet fibrinogen receptors by ADP and epinephrine.
  Journal of Clinical Investigation, 1979